Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
JAK2 V617F mutation and associated chromosomal alterations in primary and secondary myelofibrosis and post-HCT outcomes.
Rafati M, Brown DW, Zhou W, Jones K, Luo W, St Martin A, Wang Y, He M, Spellman SR, Wang T, Deeg HJ, Gupta V, Lee SJ, Bolon YT, Chanock SJ, Machiela MJ, Saber W, Gadalla SM. Rafati M, et al. Among authors: st martin a. Blood Adv. 2023 Dec 26;7(24):7506-7515. doi: 10.1182/bloodadvances.2023010882. Blood Adv. 2023. PMID: 38011490 Free PMC article.
Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors.
Grunwald MR, Zhang MJ, Elmariah H, Johnson MH, St Martin A, Bashey A, Battiwalla M, Bredeson CN, Copelan E, Cutler CS, George BR, Gupta V, Kanakry C, Mehta RS, Milano F, Mussetti A, Nakamura R, Nishihori T, Saber W, Solh M, Weisdorf DJ, Eapen M. Grunwald MR, et al. Among authors: st martin a. Blood Adv. 2021 Feb 23;5(4):975-983. doi: 10.1182/bloodadvances.2020003654. Blood Adv. 2021. PMID: 33576783 Free PMC article.
Donor Killer Immunoglobulin Receptor Gene Content and Ligand Matching and Outcomes of Pediatric Patients with Juvenile Myelomonocytic Leukemia Following Unrelated Donor Transplantation.
Rangarajan HG, Pereira MSF, Brazauskas R, St Martin A, Kussman A, Elmas E, Verneris MR, Gadalla SM, Marsh SGE, Paczesny S, Spellman SR, Lee SJ, Lee DA. Rangarajan HG, et al. Among authors: st martin a. Transplant Cell Ther. 2021 Nov;27(11):926.e1-926.e10. doi: 10.1016/j.jtct.2021.08.009. Epub 2021 Aug 15. Transplant Cell Ther. 2021. PMID: 34407489 Free PMC article.
Veno-occlusive disease risk in pediatric patients with acute myeloid leukemia treated with gemtuzumab ozogamicin before allogeneic hematopoietic cell transplantation.
Duncan C, St Martin A, Pérez WS, Steinert P, Zhang MJ, Chirnomas D, Hoang CJ, Loberiza FR Jr, Saber W. Duncan C, et al. Among authors: st martin a. Pediatr Blood Cancer. 2021 Aug;68(8):e29067. doi: 10.1002/pbc.29067. Epub 2021 Apr 19. Pediatr Blood Cancer. 2021. PMID: 33871892 Free PMC article.
Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Cohort Study.
Bhatt NS, Sharma A, St Martin A, Abid MB, Brown VI, Diaz Perez MA, Frangoul H, Gadalla SM, Herr MM, Krem MM, Lazarus HM, Martens MJ, Mehta PA, Nishihori T, Prestidge T, Pulsipher MA, Rangarajan HG, Williams KM, Winestone LE, Yin DE, Riches ML, Dandoy CE, Auletta JJ. Bhatt NS, et al. Among authors: st martin a. Transplant Cell Ther. 2022 Oct;28(10):696.e1-696.e7. doi: 10.1016/j.jtct.2022.06.026. Epub 2022 Jul 4. Transplant Cell Ther. 2022. PMID: 35798233 Free PMC article.
Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis.
Eapen M, Wang T, Veys PA, Boelens JJ, St Martin A, Spellman S, Bonfim CS, Brady C, Cant AJ, Dalle JH, Davies SM, Freeman J, Hsu KC, Fleischhauer K, Kenzey C, Kurtzberg J, Michel G, Orchard PJ, Paviglianiti A, Rocha V, Veneris MR, Volt F, Wynn R, Lee SJ, Horowitz MM, Gluckman E, Ruggeri A. Eapen M, et al. Among authors: st martin a. Lancet Haematol. 2017 Jul;4(7):e325-e333. doi: 10.1016/S2352-3026(17)30104-7. Epub 2017 Jun 13. Lancet Haematol. 2017. PMID: 28623181 Free PMC article.
Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.
Solomon SR, St Martin A, Shah NN, Fatobene G, Al Malki MM, Ballen KK, Bashey A, Bejanyan N, Bolaños Meade J, Brunstein CG, DeFilipp Z, Champlin RE, Fuchs EJ, Hamadani M, Hematti P, Kanakry CG, McGuirk JP, McNiece IK, Ciurea SO, Pasquini MC, Rocha V, Romee R, Patel SS, Vasu S, Waller EK, Wingard JR, Zhang MJ, Eapen M. Solomon SR, et al. Among authors: st martin a. Blood Adv. 2019 Oct 8;3(19):2836-2844. doi: 10.1182/bloodadvances.2019000627. Blood Adv. 2019. PMID: 31582392 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 33851205
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide.
McCurdy SR, Zhang MJ, St Martin A, Al Malki MM, Bashey A, Gaballa S, Keesler DA, Hamadani M, Norkin M, Perales MA, Reshef R, Rocha V, Romee R, Solh M, Urbano-Ispizua A, Waller EK, Fuchs EJ, Eapen M. McCurdy SR, et al. Among authors: st martin a. Blood Adv. 2018 Feb 13;2(3):299-307. doi: 10.1182/bloodadvances.2017014829. Blood Adv. 2018. PMID: 29440002 Free PMC article.
28 results